Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes
Bruce Bartholow Duncan(Universidade Federal do Rio Grande do Sul), Gerardo Heiss(University of North Carolina at Chapel Hill), Álvaro Vigo(Universidade Federal do Rio Grande do Sul), Ron C. Hoogeveen(Baylor College of Medicine), Christie M. Ballantyne(Baylor College of Medicine), Aaron R. Folsom(University of Minnesota), María Inês Schmidt(Universidade Federal do Rio Grande do Sul), David Couper(University of North Carolina at Chapel Hill), James S. Pankow(University of Minnesota System)
Cited by 1,043
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k